Stereotaxis Magic Ablation Catheter Receives CE Mark Approval

January 27, 2025—Stereotaxis announced that it received European CE Mark approval for the Magic catheter, a robotically navigated magnetic ablation catheter designed to perform cardiac ablation procedures for heart arrhythmia.

According to the company, the Magic catheter is designed to enhance treatment precision and control during cardiac ablation while maintaining the safety advantage of a soft flexible catheter.

Stereotaxis advised that the Magic catheter has been approved in Europe with a broad label that includes the delivery of “local lesions in cardiac tissue for the treatment of cardiac arrhythmias.”

As outlined in the company’s press release, the Magic device builds upon existing benefits of robotic cardiac ablation while incorporating design enhancements, including:

• Optimized navigation, force, and stability: The placement of magnets and design of the distal section of the catheter supports intuitive navigation, consistent contact forces, and enhanced stability.
• Improved data and information: Magic is available with iConnect and the eContact module, offering catheter tissue contact information as well as clear electrogram and responsive temperature data to support physician decision-making.
• Efficient low-flow uniform cooling: Cooling of the tip is accomplished with low-flow irrigation that substantially reduces overall fluid load on patients while protecting against char and coagulation.